Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

STELLA-LONG TERM, a 3-year post-marketing surveillance study, evaluated the safety and effectiveness of the sodiumglucose cotransporter 2 inhibitor ipragliflozin in Japanese type 2 diabetes mellitus (T2DM) patients. Final results in the safety (n = 6697) and effectiveness populations (n = 5625) were...

Full description

Saved in:
Bibliographic Details
Main Authors: K. Tobe, H. Maegawa, I. Nakamura, S. Uno
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2021
Subjects:
diabetes mellitus
ipragliflozin
post-marketing surveillance
renal impairment
sodium-glucose cotransporter 2 inhibitor
Nutritional diseases. Deficiency diseases
RC620-627
Online Access:https://doaj.org/article/d0c41f975f364f238c654af6629cd7b2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/d0c41f975f364f238c654af6629cd7b2

Similar Items